Trademarkia Logo

Canada

C$
Trademark Search in Canada
DIANTHUS THERAPEUTICS

View On IC.GC.CA

DIANTHUS THERAPEUTICS
APPROVED

on 17 Apr 2025

Last Applicant/ Owned by

Dianthus Therapeutics OPCO, Inc.

204 Crescent StreetBuilding 4, Suite 205Waltham, MA 02453

US

Serial Number

2219277 filed on 1st Nov 2022

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

DIANTHUS THERAPEUTICS

Trademark usage description

monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases research and development services for the development Read More

Classification Information

Class [001]
Monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Classification kind code

11

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Research and development services for the development of monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases; clinical trials for others involving monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases

Classification kind code

11

Mark Details

Serial Number

2219277

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 26
on 17th Apr 2025		Approved
Submitted for opposition 27
on 17th Apr 2025		Approval Notice Sent
Submitted for opposition 22
on 9th Apr 2025		Search Recorded
Submitted for opposition 135
on 30th Apr 2024		Amendment to Application
Submitted for opposition 287
on 10th Nov 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 1st Nov 2022		Filed
Submitted for opposition 1
on 1st Nov 2022		Created
Submitted for opposition 31
on 1st Nov 2022		Formalized